환자 체온 모니터링 시장 예측(2026-2032년)

The Patient Temperature Monitoring Market is projected to grow by USD 3.61 billion at a CAGR of 6.41% by 2032.

Patient temperature monitoring is a core vital-sign function across emergency care, inpatient wards, intensive care, perioperative settings, neonatal care, infectious disease triage, home healthcare, and remote patient monitoring programs. The category spans contact thermometers, non-contact infrared thermometers, wearable temperature sensors, continuous core-temperature monitoring systems, smart patches, connected bedside monitors, and integrated clinical surveillance platforms. Demand is supported by the clinical importance of early fever detection, perioperative normothermia management, sepsis surveillance, neonatal thermal stability, and infection prevention workflows.

Healthcare systems are moving from episodic spot checks toward connected, continuous, and context-aware temperature monitoring. This shift is driven by the need to identify clinical deterioration earlier, reduce manual documentation burden, support remote and decentralized care, and improve visibility across high-acuity and high-throughput environments. Regulatory expectations, device accuracy standards, cybersecurity requirements, interoperability needs, and evidence-based clinical validation are increasingly shaping purchasing decisions. As a result, the patient temperature monitoring landscape is becoming less device-centric and more focused on integrated data, workflow automation, and actionable clinical intelligence.

Transformative Shifts in Temperature Monitoring

The patient temperature monitoring landscape is being reshaped by the convergence of continuous sensing, wireless connectivity, hospital-at-home models, and infection control priorities. Traditional mercury-based measurement has been displaced in many settings by digital, infrared, tympanic, temporal artery, esophageal, bladder, rectal, and wearable technologies, reflecting broader healthcare emphasis on safety, speed, accuracy, and environmental responsibility. At the same time, non-contact approaches gained operational relevance in screening and triage because they can reduce device-to-patient contact, though clinical-grade use still depends on proper calibration, controlled measurement conditions, and alignment with validated protocols.

A major transformation is the integration of temperature data into electronic health records, bedside monitoring networks, early warning systems, and remote patient monitoring dashboards. This allows clinicians to evaluate fever trends alongside heart rate, respiratory rate, oxygen saturation, blood pressure, and patient-reported symptoms. Hospitals are also prioritizing devices that support automated charting, alarm management, and interoperability standards to reduce documentation errors and alert fatigue. In home and ambulatory settings, connected thermometers and wearable sensors are enabling longitudinal fever tracking for post-discharge monitoring, chronic disease management, oncology care, pediatrics, and infectious disease follow-up.

Procurement criteria are also changing. Buyers increasingly evaluate clinical accuracy across patient populations, usability for nurses and caregivers, cleaning requirements, battery life, connectivity reliability, data security, and compatibility with existing clinical infrastructure. Temperature monitoring is therefore evolving from a basic measurement task into a strategic element of patient surveillance, operational efficiency, and value-based care delivery.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is expanding the value of patient temperature monitoring by turning isolated readings into predictive and contextual clinical signals. AI-enabled analytics can help detect abnormal temperature trajectories, identify patterns associated with infection risk or deterioration, and combine temperature trends with vital signs, laboratory results, medications, comorbidities, and clinical notes. This cumulative impact is especially relevant in intensive care, emergency departments, oncology units, long-term care, and remote monitoring programs where early recognition of change can support faster escalation.

AI also enhances workflow efficiency. Algorithms embedded in clinical surveillance systems can prioritize patients with concerning fever patterns, reduce noise from non-actionable alerts, and support triage decisions when temperature data are combined with other physiological indicators. In remote care, AI can help distinguish meaningful trends from measurement variability caused by device placement, ambient temperature, user technique, or intermittent connectivity. For wearable temperature sensors, machine learning models can support baseline personalization because normal temperature patterns vary by age, circadian rhythm, activity, medication use, and individual physiology.

However, AI adoption in temperature monitoring requires disciplined governance. Clinical validation, bias assessment, explainability, cybersecurity, data privacy, and human oversight are essential. Temperature is a sensitive but non-specific marker, and AI outputs must be interpreted in clinical context rather than treated as stand-alone diagnoses. The strongest use cases are those that augment clinician judgment, improve surveillance reliability, and integrate seamlessly with established care pathways.

Key Regional Insights for Patient Temperature Monitoring

In Asia-Pacific, patient temperature monitoring adoption is supported by expanding hospital infrastructure, high population density, growing digital health initiatives, and sustained attention to infectious disease preparedness. Countries with advanced healthcare systems are emphasizing connected monitoring, perioperative temperature control, and remote care integration, while emerging economies are expanding access to affordable digital and infrared thermometers across public and private care settings. The region's diversity creates strong demand for scalable devices that can serve tertiary hospitals, community clinics, and home-based care.

North America remains strongly oriented toward connected and standards-compliant patient monitoring, driven by widespread electronic health record use, remote patient monitoring reimbursement pathways, hospital quality programs, and heightened focus on sepsis and deterioration surveillance. Hospitals and ambulatory providers prioritize interoperability, automated documentation, cybersecurity, and clinically validated devices. Home healthcare and virtual care programs continue to increase the relevance of consumer-friendly but clinically reliable temperature measurement.

Latin America is seeing growing use of digital and infrared thermometry across hospitals, pharmacies, clinics, and home care, supported by public health surveillance needs and private healthcare modernization. Adoption patterns vary by country and income segment, with affordability, distribution reach, and training influencing device selection. Europe emphasizes patient safety, medical device regulation, environmental considerations, and interoperable digital health infrastructure. The region's strong focus on hospital infection control, perioperative quality, and aging populations supports demand for reliable temperature monitoring across acute and long-term care settings.

The Middle East is investing in modern hospital systems, smart healthcare infrastructure, and digital public health capabilities, particularly in high-income Gulf countries where connected monitoring and hospital digitalization are advancing rapidly. Africa presents a mixed landscape shaped by infectious disease burden, maternal and child health priorities, resource constraints, and uneven healthcare infrastructure. In many African settings, robust, affordable, easy-to-clean, and battery-efficient temperature monitoring tools remain critical, while urban hospitals and private providers are gradually adopting more connected solutions.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, patient temperature monitoring demand is shaped by expanding healthcare access, urban hospital investment, infectious disease surveillance, and growing digital health adoption. Diverse income levels and healthcare infrastructure mean that both low-cost digital thermometers and connected monitoring platforms remain relevant. Procurement often emphasizes affordability, durability, multilingual usability, and compatibility with public health workflows.

The GCC is characterized by high investment in advanced healthcare infrastructure, medical tourism, and digital hospital transformation. Patient temperature monitoring in this group is increasingly linked to smart hospitals, electronic medical records, perioperative care standards, and remote health initiatives. Device selection often emphasizes interoperability, premium clinical performance, procurement standardization, and integration with broader patient monitoring networks.

The European Union is shaped by stringent medical device regulation, data protection rules, patient safety goals, and sustainability priorities. Temperature monitoring adoption is strongly influenced by clinical evidence, conformity requirements, cybersecurity expectations, and integration with digital health systems. Aging demographics and chronic disease management further support the need for reliable monitoring in hospitals, long-term care, and home settings.

BRICS countries collectively represent highly varied healthcare environments, combining large patient populations, expanding hospital networks, local manufacturing ambitions, and rising digital health investment. China and India are particularly important for scalable deployment across public health and private hospital systems, while Brazil, Russia, and South Africa show demand across infectious disease management, critical care, and primary care access. The G7 group reflects mature healthcare systems where advanced patient monitoring is closely tied to quality improvement, workforce efficiency, and remote care. NATO countries overlap significantly with advanced and middle-income health systems where hospital readiness, emergency response, and secure digital infrastructure are important considerations for connected monitoring technologies.

Key Country Insights for Patient Temperature Monitoring

In the United States, patient temperature monitoring is closely linked to hospital quality initiatives, remote patient monitoring, EHR integration, and early warning systems for sepsis and clinical deterioration. Providers emphasize validated accuracy, workflow fit, automated documentation, and cybersecurity. Canada shows similar priorities, with additional emphasis on equitable access across urban, rural, and remote communities, making reliable home and primary care temperature monitoring important. Mexico combines demand from public hospitals, private healthcare providers, pharmacies, and home care, with affordability and distribution access influencing adoption.

Brazil is a significant Latin American market for patient temperature monitoring due to its large healthcare system, infectious disease surveillance needs, and expanding private hospital sector. In the United Kingdom, adoption is shaped by national health service workflows, infection control, virtual wards, and digital care initiatives. Germany prioritizes high-quality medical devices, hospital automation, regulatory compliance, and advanced clinical engineering standards. France emphasizes patient safety, hospital modernization, and integrated care, while Italy and Spain show strong relevance for temperature monitoring in aging populations, chronic disease care, and public hospital networks. Russia's demand is influenced by large geographic scale, hospital-based care needs, and domestic healthcare modernization efforts.

China is advancing connected patient monitoring through large-scale hospital digitalization, domestic device production, and growing use of smart healthcare infrastructure. India's needs are shaped by high patient volumes, expanding hospital capacity, infectious disease management, telehealth growth, and the need for cost-effective devices suitable for both urban and rural settings. Japan emphasizes precision, elderly care, hospital quality, and home health technologies, making continuous and minimally disruptive monitoring important. Australia focuses on remote care delivery, hospital interoperability, and access across geographically dispersed populations. South Korea benefits from advanced digital infrastructure, strong hospital technology adoption, and interest in connected healthcare solutions that support efficient clinical workflows.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated accuracy across diverse care settings and patient populations, including pediatrics, geriatrics, perioperative patients, critical care patients, and home users. Product development should focus on ease of use, infection control, fast response time, continuous monitoring capability, robust connectivity, and seamless integration with clinical information systems. For connected devices, compliance with cybersecurity, privacy, and interoperability expectations is no longer optional; it is central to procurement acceptance.

Manufacturers and solution providers should build evidence around workflow impact, documentation efficiency, alarm management, and clinical outcomes rather than relying only on device specifications. Training and implementation support are critical because measurement technique, sensor placement, ambient conditions, and cleaning protocols can materially affect performance. In emerging markets, affordability, durability, battery efficiency, and local service support are essential differentiators. In mature markets, value increasingly comes from analytics, automation, integration, and lifecycle reliability.

Leaders should also align portfolios with decentralized care models. Home healthcare, post-discharge monitoring, long-term care, and virtual wards require devices that are simple for patients and caregivers but reliable enough for clinical decision-making. Partnerships with healthcare systems, standards bodies, and digital health platforms can improve adoption, while transparent validation data and responsible AI governance can strengthen trust.

Research Methodology

This executive summary is developed through a structured secondary research approach focused on verified, publicly available, and data-backed healthcare, regulatory, and technology sources. The methodology considers clinical guidelines, medical device regulatory frameworks, standards related to thermometry and connected health technologies, public health documentation, healthcare digitalization trends, peer-reviewed literature on temperature measurement accuracy, and evidence on remote patient monitoring and clinical surveillance workflows.

The analysis examines patient temperature monitoring across care settings, technology types, regional healthcare infrastructure, regulatory conditions, and adoption drivers. Insights are synthesized qualitatively to identify structural trends, regional differences, group-level dynamics, country-specific considerations, AI implications, and strategic priorities. The approach avoids market sizing, share estimation, and forecasting, focusing instead on verifiable industry developments, clinical use cases, procurement factors, and operational realities that influence adoption.

Conclusion

Patient temperature monitoring is transitioning from a routine vital-sign measurement into a connected clinical intelligence function. The most important advances are not limited to faster thermometers or new sensor formats; they involve continuous monitoring, interoperability, remote care enablement, AI-assisted surveillance, and better integration into clinical workflows. Hospitals, clinics, long-term care providers, and home healthcare programs increasingly require solutions that are accurate, secure, easy to use, and capable of supporting timely decisions.

Regional adoption will continue to reflect differences in healthcare infrastructure, digital maturity, regulatory expectations, and affordability requirements. Mature systems are prioritizing integration, automation, and advanced analytics, while emerging settings continue to value access, durability, and cost-effective deployment. Across all markets, success depends on clinical validation, workflow relevance, patient safety, and trust. Industry leaders that combine reliable measurement with connected data, responsible AI, and practical implementation support will be best positioned to meet the evolving needs of patient temperature monitoring.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Patient Temperature Monitoring Market, by Product Type

• 7.1. Introduction
• 7.2. Digital Thermometers
  • 7.2.1. Handheld Digital Thermometers
  • 7.2.2. Wearable Digital Thermometers
• 7.3. Infrared Thermometers
  • 7.3.1. Forehead Infrared Thermometers
  • 7.3.2. Tympanic Infrared Thermometers
• 7.4. Liquid-In-Glass Thermometers
• 7.5. Zero Heat Flux Thermometers

8. Patient Temperature Monitoring Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Offline
  • 8.2.1. Health & Wellness Stores
  • 8.2.2. Specialty Stores
  • 8.2.3. Supermarkets/Hypermarkets
• 8.3. Online
  • 8.3.1. Company Websites
  • 8.3.2. E-commerce Platforms

9. Patient Temperature Monitoring Market, by Application

• 9.1. Introduction
• 9.2. Anesthesia
• 9.3. Blood Transfusion
• 9.4. Hypothermia
• 9.5. Pyrexia/Fever

10. Patient Temperature Monitoring Market, by End User

• 10.1. Introduction
• 10.2. Clinics
• 10.3. Homecare
• 10.4. Hospitals
• 10.5. Research Institutions

11. Patient Temperature Monitoring Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Patient Temperature Monitoring Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Patient Temperature Monitoring Market, by Country

• 13.1. United States
• 13.2. Germany
• 13.3. China
• 13.4. United Kingdom
• 13.5. India
• 13.6. Japan
• 13.7. Russia
• 13.8. Brazil
• 13.9. Canada
• 13.10. Italy
• 13.11. Mexico
• 13.12. France
• 13.13. Spain
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Share Analysis, 2025
• 14.2. FPNV Positioning Matrix, 2025
• 14.3. Market Concentration Analysis, 2025
  • 14.3.1. Concentration Ratio (CR)
  • 14.3.2. Herfindahl Hirschman Index (HHI)
• 14.4. Recent Developments & Impact Analysis, 2025
• 14.5. Product Portfolio Analysis, 2025
• 14.6. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. 3M Company
• 15.2. A&D Co., Ltd.
• 15.3. American Diagnostic Corporation
• 15.4. Becton, Dickinson and Company
• 15.5. Beurer GmbH
• 15.6. Cardinal Health Inc.
• 15.7. Cosinuss GmbH
• 15.8. DeltaTrak
• 15.9. Dragerwerk AG & Co. KGaA
• 15.10. Dwyer Instruments, LLC
• 15.11. Exergen Corporation
• 15.12. Geratherm Medical AG
• 15.13. Hill-Rom Holdings, Inc. by Baxter International Inc.
• 15.14. iHealth Labs Inc
• 15.15. Kinsa Inc. by Healthy Together
• 15.16. Koninklijke Philips N.V.
• 15.17. Masimo Corp.
• 15.18. Medisana GmbH
• 15.19. Medtronic PLC
• 15.20. Microlife Corporation
• 15.21. Nureca Ltd.
• 15.22. Omron Healthcare Inc.
• 15.23. Paul Hartmann AG
• 15.24. SteadySense GmbH
• 15.25. Terumo Corporation
• 15.26. VivaLNK, Inc.